Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56(bright) NK cell subpopulations in patients with acute myeloid leukemia and supports their activation

Histamine dihydrochloride (HDC) plus IL-2 has been proposed as a novel maintenance-immunotherapy in acute myeloid leukemia (AML). We analyzed the immunophenotype and function of natural killer (NK) cells in blood of AML patients treated after chemotherapy with HDC plus IL-2. The treatment caused a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuapio, Angélica, Post, Mirte, Cerny-Reiterer, Sabine, Gleixner, Karoline V., Stefanzl, Gabriele, Basilio, Jose, Herndlhofer, Susanne, Sperr, Wolfgang R., Brons, Nicolaas H.C., Casanova, Emilio, Zimmer, Jacques, Valent, Peter, Hofer, Erhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216810/
https://www.ncbi.nlm.nih.gov/pubmed/27341131
http://dx.doi.org/10.18632/oncotarget.10191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216810/
https://www.ncbi.nlm.nih.gov/pubmed/27341131
http://dx.doi.org/10.18632/oncotarget.10191

Ejemplares similares